courseraЗдоровье

Molecular Tumor Board 2023-2024

Курс от Universitat de Barcelona

Средний≈ 42.8 чИспанский

О курсе

Se trata de un curso que nace a raíz de una de las sesiones formativas que realiza cada 15 días el Servicio de Oncología Médica del Hospital Clínic de Barcelona (HCB). En este curso se presentan casos clínicos simulando un MTB de tumores sólidos, con un objetivo principal, mejorar el conocimiento específico del impacto clínico del perfil molecular en tumores sólidos. Está destinado a médicos oncólogos y a estudiantes y profesionales vinculados a la oncología médica. Cada seminario que conforma el curso lo presenta un profesional de una patología diferente del Servicio de Oncología Médica del HCB.

Навыки, которые вы освоите

Oncology Molecular Biology Precision Medicine Pharmacotherapy Clinical Trials Pharmacology Clinical Research Urology Pathology Patient Treatment Treatment Planning Immunology

Программа курса

17 модулей · 51 учебных материалов

01Is there any role for presicion medicine in ampullary cancer? by Dra. Tamara Sauri3 материалов

02Targeted therapy in upper tract urinary cancer by Dra. Laia Fernández

Учитесь у экспертов

Dra. Laura Mezquita Perez

Servicio de Oncología Médica

Dr. Aleix Prat Aparicio

Team Leader "Translational genomics and targeted therapies in solid tumours"

Eva Paradell Salinas

COORDINACIÓN EJECUTIVA

Mercè Moreda

Преподаватель курса

3 материалов

03What are the odds? Not everything that glitters is gold by Dr. Lucio Ghiglione3 материалов

Seminario

What are the odds? Not everything that glitters is goldВидео

Lecturas recomendadas

10 Publicaciones recomendadasЧтение

Cuestionario

What are the odds? Not everything that glitters is goldЗадание

04Beyond HER2 amplification: do HER2 mutations play a role in Breast Cancer? by Dra. Isabel García3 материалов

Seminario

Beyond HER2 amplification: do HER2 mutations play a role in Breast Cancer? Видео

Lecturas recomendadas

11 Publicaciones recomendadasЧтение

Cuestionario

Beyond HER2 amplification: do HER2 mutations play a role in Breast Cancer? Задание

05Unexpected response to IO in a patient with advanced colorectal cancer by Dr. Juan Carlos Laguna3 материалов

Seminario

Unexpected response to IO in a patient with advanced colorectal cancerВидео

Lecturas recomendadas

5 Publicaciones recomendadasЧтение

Cuestionario

Unexpected response to IO in a patient with advanced colorectal cancerЗадание

06Ataxia Teleangectasia Mutations (ATM) and advanced prostate cancer by Dra. Caterina Aversa3 материалов

Seminario

Ataxia Teleangectasia Mutations (ATM) and advanced prostate cancerВидео

Lecturas recomendadas

10 Publicaciones recomendadasЧтение

Lección sin título

Ataxia Teleangectasia Mutations (ATM) and advanced prostate cancerЗадание

07dMMR/MSI-H facor predictivo en CCR localizado by Dr. Reinaldo Moreno3 материалов

Seminario

dMMR/MSI-H facor predictivo en CCR localizadoВидео

Lecturas recomendadas

6 Publicaciones recomendadasЧтение

Cuestionario

dMMR/MSI-H facor predictivo en CCR localizadoЗадание

08Multiples tumors in a young patient ¿genetic or casuality? by Dra. Laura González3 материалов

Seminario

Multiples tumors in a young patient ¿genetic or casuality?Видео

Lecturas recomendadas

8 Publicaciones recomendadasЧтение

Cuestionario

Multiples tumors in a young patient ¿genetic or casuality?Задание

09Tackling KRAS G12C mutation in NSCLC by Dr. Francisco Javier Muñoz3 материалов

Seminario

Tackling KRAS G12C mutation in NSCLCВидео

Lecturas recomendadas

13 Publicaciones recomendadasЧтение

Cuestionario

Tackling KRAS G12C mutation in NSCLCЗадание

10Presicion Medicine in NSCLC by Dra. Laura Mezquita3 материалов

Seminario

Presicion Medicine in NSCLCВидео

Lecturas recomendadas

4 Publicaciones recomendadasЧтение

Cuestionario

Presicion Medicine in NSCLCЗадание

11Molecular characterization of agressive prostate cancer by Dra. Marta Garcia de Herreros3 материалов

Seminario

Molecular characterization of agressive prostate cancerВидео

Lecturas recomendadas

7 Publicaciones recomendadasЧтение

Cuestionario

Molecular characterization of agressive prostate cancerЗадание

12Understanding the True Impact of Molecular Alterations by Dr. David Pesántez 3 материалов

Seminario

Understanding the True Impact of Molecular AlterationsВидео

Lecturas recomendadas

5 Publicaciones recomendadasЧтение

Cuestionario

Understanding the True Impact of Molecular AlterationsЗадание

13PARP inhibitors in somatic BRCA-mutant breast cancer: beyond germline pathogenetic variants by Dr. Francesco Schettini3 материалов

Seminario

PARP inhibitors in somatic BRCA-mutant breast cancer: beyond germline pathogenetic variantsВидео

Lecturas recomendadas

8 Publicaciones recomendadasЧтение

Cuestionario

PARP inhibitors in somatic BRCA-mutant breast cancer: beyond germline pathogenetic variantsЗадание

14Personalized Treatment Strategies in Metastatic Colon Cancer by Dra. Mariam Rojas3 материалов

Seminario

Personalized Treatment Strategies in Metastatic Colon CancerВидео

Lecturas recomendadas

8 Publicaciones recomendadasЧтение

Cuestionario

Personalized Treatment Strategies in Metastatic Colon CancerЗадание

15Beyond BRCAs in prostate cancer by Dr. Òscar Reig3 материалов

Seminario

Beyond BRCAs in prostate cancerВидео

Lecturas recomendadas

5 Publicaciones recomendadasЧтение

Cuestionario

Beyond BRCAs in prostate cancerЗадание

16Targeted cholangiocarcinoma: myth or reality by Dr. Iván Victoria3 материалов

Seminario

Targeted cholangiocarcinoma: myth or realityВидео

Lecturas recomendadas

5 Publicaciones recomendadasЧтение

Cuestionario

Targeted cholangiocarcinoma: myth or realityЗадание

17Rediscovering the uncharted EGFR uncommon mutations by Dra. Teresa Gorria3 материалов

Seminario

Rediscovering the uncharted EGFR uncommon mutationsВидео

Lecturas recomendadas

8 Publicaciones recomendadasЧтение

Cuestionario

Rediscovering the uncharted EGFR uncommon mutationsЗадание